Watt JL, Olson IA, Johnston AW, et al. A familial pericentric inversion of chromosome 22 with a recombinant subject illustrating a ‘pure’ partial monosomy syndrome[J]. J Med Genet, 1985, 22 (4): 283-287.
[3]
Bonaglia MC, Giorda R, Mani E, et al. Identification of a recurrent breakpoint within the SHANK3 gene in the 22q13.3 deletion syndrome[J]. J Med Genet, 2006, 43(10): 822-828.
[4]
Cusmano-Ozog K, Manning MA, Hoyme HE. 22q13.3 deletion syndrome: a recognizable malformation syndrome associated with marked speech and language delay[J]. Am J Med Genet C Semin Med Genet, 2007, 145C(4): 393-398.
[5]
Dhar SU, del Gaudio D, German JR, et al. 22q13.3 deletion syndrome: clinical and molecular analysis using array CGH[J]. Am J Med Genet A, 2010, 152A(3): 573-581.
[6]
Phelan MC, Stapleton GA, Rogers RC. The Management of Genetic Syndromes[M]. Wiley-Liss, Inc., Hoboken, 2010.
Durand CM, Betancur C, Boeckers TM, et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders[J]. Nat Genet, 2007, 39(1): 25-27 .
[9]
Manning MA, Cassidy SB, Clericuzio C, et al. Terminal 22q deletion syndrome: a newly recognized cause of speech and language disability in the autism spectrum[J]. Pediatrics, 2004, 114(2): 451-457.
[10]
Phelan K. 22q13.3 deletion syndrome[M]//Pagon RA, Bird TD, Dolan CR, et al. Gene Tests: GeneReviews [Internet]. University of Washington, Seattle, WA, 2007.
[11]
Wilson HL, Wong ACC, Shaw SR, et al. Molecular characterization of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms[J]. J Med Genet, 2003, 40(8): 575-584.
[12]
Bonaglia MC, Giorda R, Borgatti R, et al. Disruption of the ProSAP2 gene in at(12;22)(q24.1;q13.3) is associated with the 22q13.3 deletion syndrome[J]. Am J Hum Genet, 2002, 69(2): 261-268.
[13]
Sarasua SM, Dwivedi A, Boccuto L, et al. Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome)[J]. J Med Genet, 2011, 48(11): 761-766.
[14]
Sarasua SM, Dwivedi A, Boccuto L, et al. 22q13.2q13.32 genomic regions associated with severity of speech delay, developmental delay, and physical features in Phelan-McDermid syndrome[J]. Genet Med, 2014, 16(4): 318-328.
[15]
Shcheglovitov A, Shcheglovitova O, Yazawa M, et al. SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients[J]. Nature, 2013, 503(7475): 267- 271.
